Diagnostics Press Releases

First Light Diagnostics MultiPath™ Part of Innovation Alley at IDWeek 2019

First Light Diagnostics MultiPath™ Part of Innovation Alley at IDWeek 2019

First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced their participation at IDWeek 2019 from Oct. 2 – 6 in Washington, DC. First Light Diagnostics…

ChunLab Releases Beta Version of TrueBac ID, the Genome-Based Diagnostic Solution for Bacterial Identification

ChunLab Releases Beta Version of TrueBac ID, the Genome-Based Diagnostic Solution for Bacterial Identification

​​​ChunLab, a leader in the field of bioinformatics for bacterial taxonomy and microbiome, released the beta version of TrueBacTM ID system, the world’s first genome-based cloud solution for bacterial identification, targeting over 12,000 species. Accurate bacterial identification has been a scientific…

First Light Diagnostics MultiPath™ Platform to Be Showcased at AACC 2019

First Light Diagnostics MultiPath™ Platform to Be Showcased at AACC 2019

​First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation at the American Association for Clinical Chemistry’s (AACC) 71st Annual Scientific Meeting & Clinical Lab Expo in…

First Light Diagnostics Receives Technology Innovation Leader Award at Frost & Sullivan Gala

First Light Diagnostics Receives Technology Innovation Leader Award at Frost & Sullivan Gala

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, formally received their award for Technology Innovation at the 2019 Frost & Sullivan Excellence in Best Practices Awards Gala on July…

First Light Adds New Multimedia to Website

First Light Adds New Multimedia to Website

​​First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the introduction of new multimedia content on the homepage of the First Light Diagnostics website.  The new content offers…

First Light Diagnostics Announces Closing of a $4.5 Million Debt Financing

First Light Diagnostics Announces Closing of a $4.5 Million Debt Financing

First Light Diagnostics Inc., a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the closing of a $4.5 million debt financing. This includes a Lease Line with CSC Leasing of Virginia…

Akonni Biosystems Receives FDA 510(k) Clearance of Its TruDiagnosis Multiplex Diagnostic System

Akonni Biosystems Receives FDA 510(k) Clearance of Its TruDiagnosis Multiplex Diagnostic System

​​​​​​Akonni Biosystems Inc. announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for its TruDiagnosis® System. With this approval, Akonni is poised to enter the $8B molecular diagnostics market. The TruDiagnosis® System is a compact point…

First Light Diagnostics to Showcase MultiPath™ Platform at ASM Microbe 2019

First Light Diagnostics to Showcase MultiPath™ Platform at ASM Microbe 2019

 First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced its participation at the American Society for Microbiology's ASM Microbe 2019 Event in San Francisco, California, from June 20-24. First Light…

510(k) Market Clearance for FluChip-8G Influenza A+B Assay

510(k) Market Clearance for FluChip-8G Influenza A+B Assay

​​​​​InDevR Inc., a leader in progressive analytical technologies, announced today that they have received 510(k) market clearance for their FluChip-8G Influenza A+B Assay from the United States Food and Drug Administration (FDA). FluChip-8G is the first cleared influenza diagnostic capable…

First Light Diagnostics Welcomes New Vice President of Quality Assurance and Regulatory Affairs

First Light Diagnostics Welcomes New Vice President of Quality Assurance and Regulatory Affairs

​First Light Diagnostics, a developer of breakthrough automated products for the rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the hiring of Andrew Connerty as its vice president of quality assurance and regulatory affairs.        …

Inanovate Inc. Secures $3.1M Investment to Support Breast Cancer Detection Technology

Inanovate, Inc., a life science company specializing in the development of blood tests for cancer and autoimmune diseases, has secured an initial closing of $3.1million on a Series C financing round. The investment, led by South Dakota Equity Partners, Mr.…

First Light Diagnostics Recognized by Frost & Sullivan as Technology Innovation Leader

First Light Diagnostics Recognized by Frost & Sullivan as Technology Innovation Leader

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced it has been recognized by Frost & Sullivan for best practices in Technology Innovation in the Rapid Diagnostics Industry. Frost…

Dr. Stephen Brecher Joins First Light Diagnostics Clinical Advisory Board

Dr. Stephen Brecher Joins First Light Diagnostics Clinical Advisory Board

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Stephen Brecher to the company’s world-class, international Clinical Advisory Board. “Stephen is an internationally recognized…

First Light Diagnostics Forms World-Class International Clinical Advisory Board

First Light Diagnostics Forms World-Class International Clinical Advisory Board

First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the establishment of a Clinical Advisory Board (CAB). The board is a growing list of members asked to…

Resolution Continues Annual Support for Arkansas Fire Department and Camp Sunshine

Resolution Development Services Inc., a leading provider of product development services to the medical, life science and consumer markets, today announced a contribution of $3000.00 to Camp Sunshine, an organization dedicated to pediatric and adult burn victims. Camp Sunshine was…

Molecular Loop Acquires MIP-Based DNA Targeting Technology

Molecular Loop Biosolutions LLC, a company specializing in advanced sample preparation solutions and data analysis for next-generation DNA sequencing, is pleased to announce the acquisition of Good Start Genetics’ molecular inversion probe-based DNA targeting and analysis technology from Invitae Corporation.…

Resolution Supports Client's 510(k) Submission for Class II Medical Device

Resolution Development Services Inc., a leading provider of product development services to the medical, life science and consumer markets, today announced the completion of the 510(k) pre-market submission for FDA review by a class II medical device customer for their next…

Flow Cytometry-Based Tools to Enrich Your Preclinical Immuno-Oncology Research, New Webinar Hosted by Xtalks

In a live broadcast upcoming on Wednesday, May 16, 2018, at 1 p.m. EDT, industry experts from MI Bioresearch Dylan Daniel, Ph.D., director of scientific development, and David Draper, Ph.D., associate director of scientific development, will describe advances in flow…

Overcoming the Challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics, New Webinar Hosted by Xtalks

In this webinar, featured speaker Erin Newburn, Associate Director and Field Applications Scientist from Personalis, Inc. will discuss how a combined whole exome and transcriptome platform such as ACE ImmunoID™ can help to overcome obstacles of immuno-oncology biomarker discovery. Topics include: Generating…

IoT (Internet of Things) Innovation in Healthcare, New Webinar Hosted by Xtalks

Internet of Things (IoT) in the healthcare industry is rapidly emerging with new business cases evolving every week. Potential benefits include using IoT to monitor patients and securely manage data during and after care. While new ideas are plentiful, execution…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login